Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without ...

The drugmaker said it has started selling higher doses of the injectable treatment for $349 a month to patients paying the full bill.

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of ...

NEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it. Kiran, a 27-year-old financial trader who has ...

Some people taking popular new diabetes and weight-loss drugs including Ozempic, Wegovy, Zepbound and Mounjaro have reported reduced cravings for substances besides food. The medications seem to ...

Listen to more stories on the Noa app. Sign up for Being Human, our newsletter that explores wellness culture, human behavior, mortality and disease, and other mysteries of the body and the mind. An ...

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...

Add Sam's Club to the list of retail pharmacy options for consumers who want to buy the pricey weight-loss drugs Ozempic and Wegovy. Sam's Club pharmacies now sell Novo Nordisk's Wegovy and Ozempic ...